Skip to Main Content

KMAP BULLETIN: Pharmaceutical Prior Authorization – June 2025 Updates

Date: 06/24/25

KMAP GENERAL BULLETIN 25134 (PDF)

Effective with dates of service on or after June 1, 2025, the following medications will become Non-Preferred and require a Preferred Drug List (PDL) Prior Authorization (PA):

  • Gabarone™ (gabapentin)

Effective with dates of service on or after June 1, 2025, the following medications will be changed to Preferred and will not require a PDL Prior Authorization (PA):

  • Wegovy® (semaglutide)

Effective with dates of service on or after June 1, 2025, the following medications will be removed from the PDL:

  • Gelnique® (oxybutynin)
  • Qdolo™ (tramadol hydrochloride)

 

Note: The effective date of the policy is June 1, 2025. The implementation of State policy by the KanCare Managed Care Organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates once the policy is implemented.